AU2095701A - 25678, a novel human adenylate cyclase - Google Patents

25678, a novel human adenylate cyclase

Info

Publication number
AU2095701A
AU2095701A AU20957/01A AU2095701A AU2095701A AU 2095701 A AU2095701 A AU 2095701A AU 20957/01 A AU20957/01 A AU 20957/01A AU 2095701 A AU2095701 A AU 2095701A AU 2095701 A AU2095701 A AU 2095701A
Authority
AU
Australia
Prior art keywords
adenylate cyclase
novel human
human adenylate
novel
cyclase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU20957/01A
Inventor
Miyoung Chun
Rosana Kapeller-Libermann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Millennium Pharmaceuticals Inc
Original Assignee
Millennium Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharmaceuticals Inc filed Critical Millennium Pharmaceuticals Inc
Publication of AU2095701A publication Critical patent/AU2095701A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y406/00—Phosphorus-oxygen lyases (4.6)
    • C12Y406/01—Phosphorus-oxygen lyases (4.6.1)
    • C12Y406/01001—Aodenylate cyclase (4.6.1.1)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU20957/01A 1999-12-14 2000-12-13 25678, a novel human adenylate cyclase Abandoned AU2095701A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US46107699A 1999-12-14 1999-12-14
US09461076 1999-12-14
PCT/US2000/033797 WO2001044453A1 (en) 1999-12-14 2000-12-13 25678, a novel human adenylate cyclase

Publications (1)

Publication Number Publication Date
AU2095701A true AU2095701A (en) 2001-06-25

Family

ID=23831123

Family Applications (1)

Application Number Title Priority Date Filing Date
AU20957/01A Abandoned AU2095701A (en) 1999-12-14 2000-12-13 25678, a novel human adenylate cyclase

Country Status (2)

Country Link
AU (1) AU2095701A (en)
WO (1) WO2001044453A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1335973B1 (en) * 2000-11-13 2009-01-21 Bayer HealthCare AG human adenylate cyclase
WO2003102175A1 (en) * 2002-05-31 2003-12-11 Bayer Healthcare Ag Regulation of human adenylate cyclase, type ii

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6034071A (en) * 1994-09-16 2000-03-07 Iyengar; Srinivas Ravi V. Mutant activated GS α and adenylyl cyclase 2 for use as therapeutic agents

Also Published As

Publication number Publication date
WO2001044453A1 (en) 2001-06-21

Similar Documents

Publication Publication Date Title
AU4006800A (en) 1,2-dithiolane derivatives
AU2001230026A1 (en) 2,4-diaminothiazole derivatives
AU2186100A (en) Exercise machine
ZA985017B (en) 4"-substituted-9-deoxo-9A-aza-9a-homoerythromycin a derivatives.
IL146100A0 (en) 4,5,6,7-tetrahydroindazole derivatives as antitumor agents
HRP980043B1 (en) 8-substituted-1,3,8-triazaspiro/4,5/ decan-4-on derivatives
SI0921125T1 (en) 1,3,8-Triazaspiro(4,5)decan-4-on derivatives
AU1584701A (en) 188891, a novel human lipase
SG71173A1 (en) 1,3,8,-triaza-spiro[4,5]decan-4-on derivatives
AU2001261572A1 (en) 38594, a novel human transporter and uses thereof
AU9649598A (en) Erythromycin a, 11,12-carbamate derivatives
AU7860800A (en) Adenylate cyclase
AU9649698A (en) Erythromycin a 11, 12-carbamate derivatives
AU5434599A (en) Exerciser
AU1782201A (en) 2786, a novel human aminopeptidase
AU2095701A (en) 25678, a novel human adenylate cyclase
AU2548000A (en) A garment
AU2001241728A1 (en) 25312, a novel human agmatinase-like homolog
AU6204300A (en) 22012, a novel human carboxypeptidase
AU2002237228A1 (en) Regulation of human adenylate cyclase, type vii
AU2003224149A1 (en) N'-cyano-n-methyl-imidamide derivatives
AUPQ254299A0 (en) A garment
AU3196000A (en) 3,3'-diketotrehalose
AU2001238193A1 (en) 27802, an adenylate kinase
AU2001238707A1 (en) 32705, 23224, 27423, 32700, 32712, novel human g-proteins

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase